Latest News

Big multiple sclerosis breakthrough: Phase 1 trial safely resets patients' immune systems and reduces attack on myelin protein

A phase 1 clinical trial for the first treatment to reset the immune system of multiple sclerosis (MS) patients showed the therapy was safe and dramatically reduced patients' immune systems' reactivity to myelin by 50 to 75 percent. The therapy used billions of patients' own specially processed blood cells to create tolerance to myelin, the insulating layer that forms around nerves. In MS, the immune system attacks myelin. The approach left the normal immune system intact.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Severing nerves may shrink stomach cancers: Botox injections slow growth of stomach tumors in mice

  • Maturing brain flips function of amygdala in regulating stress hormones

  • Many solve civil justice problems on their own, rarely involving attorneys, says study

  • Zoning regulations impact where marijuana dispensaries can locate

  • Hatha yoga boosts brain function in older adults, study suggests

  • Rheumatologic diseases like lupus can initially look like neurological disorders

  • Are children who play violent video games at greater risk for depression?

  • Fighting unfairness: Children have advanced ideas about fairness

  • Studies promoting use of antidepressants for postoperative pain may be premature, review finds

  • Dyslexia: Balanced view needed on expensive lenses to improve reading

  •